Live Breaking News & Updates on Ex Pfizer Digital Medicine Executive

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company
News provided by
Share this article
Share this article
Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive Dr. Daniel R. Karlin M.D. M.A. and former Google AI/ML industry veteran Bradford Cross added to MindMed executive team 
NEW YORK, Feb. 18, 2021 /PRNewswire/  
MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading psychedelic medicine biotech company, announced that it will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring. ....

New York , United States , Bratislavsky Kraj , Slovak Republic , United Kingdom , Columbia University , Czech Republic , Robert Barrow , Dan Karlin , Danielr Karlin , Bradford Cross , Psychiatry At Tufts Medical Center , Pfizer Neuroscience Research Unit In Cambridge , University Of Colorado School Medicine , Neo Exchange Inc , Mindmed Co , Nightware Inc , Group Lead For Human Biology , Column Health , Healthmode Co , Pfizer Neuroscience Research Unit , Healthmode Inc , Medicine Mindmed Inc , Ex Pfizer Digital Medicine Executive , Artificial Intelligence , Intellectual Property ,